GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Oxford Cannabinoid Technologies Holdings PLC (FRA:0CB) » Definitions » Quick Ratio

Oxford Cannabinoid Technologies Holdings (FRA:0CB) Quick Ratio : 3.32 (As of Oct. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Oxford Cannabinoid Technologies Holdings Quick Ratio?

The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. It is calculated as a company's Total Current Assets excludes Total Inventories divides by its Total Current Liabilities. Oxford Cannabinoid Technologies Holdings's quick ratio for the quarter that ended in Oct. 2023 was 3.32.

Oxford Cannabinoid Technologies Holdings has a quick ratio of 3.32. It generally indicates good short-term financial strength.

The historical rank and industry rank for Oxford Cannabinoid Technologies Holdings's Quick Ratio or its related term are showing as below:

FRA:0CB' s Quick Ratio Range Over the Past 10 Years
Min: 1.5   Med: 6.74   Max: 22.4
Current: 3.32

During the past 5 years, Oxford Cannabinoid Technologies Holdings's highest Quick Ratio was 22.40. The lowest was 1.50. And the median was 6.74.

FRA:0CB's Quick Ratio is ranked worse than
51.58% of 1551 companies
in the Biotechnology industry
Industry Median: 3.51 vs FRA:0CB: 3.32

Oxford Cannabinoid Technologies Holdings Quick Ratio Historical Data

The historical data trend for Oxford Cannabinoid Technologies Holdings's Quick Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Oxford Cannabinoid Technologies Holdings Quick Ratio Chart

Oxford Cannabinoid Technologies Holdings Annual Data
Trend May18 May19 May20 May21 Apr23
Quick Ratio
0.39 4.14 1.50 15.83 7.69

Oxford Cannabinoid Technologies Holdings Semi-Annual Data
May19 Nov19 May20 Nov20 May21 Nov21 Oct22 Apr23 Oct23
Quick Ratio Get a 7-Day Free Trial Premium Member Only 15.83 22.39 5.79 7.69 3.32

Competitive Comparison of Oxford Cannabinoid Technologies Holdings's Quick Ratio

For the Biotechnology subindustry, Oxford Cannabinoid Technologies Holdings's Quick Ratio, along with its competitors' market caps and Quick Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Oxford Cannabinoid Technologies Holdings's Quick Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Oxford Cannabinoid Technologies Holdings's Quick Ratio distribution charts can be found below:

* The bar in red indicates where Oxford Cannabinoid Technologies Holdings's Quick Ratio falls into.



Oxford Cannabinoid Technologies Holdings Quick Ratio Calculation

The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. For this reason, the ratio excludes inventories from current assets.

Oxford Cannabinoid Technologies Holdings's Quick Ratio for the fiscal year that ended in Apr. 2023 is calculated as

Quick Ratio (A: Apr. 2023 )=(Total Current Assets-Total Inventories)/Total Current Liabilities
=(5.097-0)/0.663
=7.69

Oxford Cannabinoid Technologies Holdings's Quick Ratio for the quarter that ended in Oct. 2023 is calculated as

Quick Ratio (Q: Oct. 2023 )=(Total Current Assets-Total Inventories)/Total Current Liabilities
=(3.218-0)/0.969
=3.32

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Oxford Cannabinoid Technologies Holdings  (FRA:0CB) Quick Ratio Explanation

The quick ratio is more conservative than the Current Ratio because it excludes inventories from current assets. The ratio derives its name presumably from the fact that assets such as cash and marketable securities are quick sources of cash. Inventories generally take time to be converted into cash, and if they have to be sold quickly, the company may have to accept a lower price than book value of these inventories. As a result, they are justifiably excluded from assets that are ready sources of immediate cash.

In general, low or decreasing quick ratios generally suggest that a company is over-leveraged, struggling to maintain or grow sales, paying bills too quickly or collecting receivables too slowly. On the other hand, a high or increasing quick ratio generally indicates that a company is experiencing solid top-line growth, quickly converting receivables into cash, and easily able to cover its financial obligations. Such companies often have faster inventory turnover and cash conversion cycles.

The higher the quick ratio, the better the company's liquidity position.


Oxford Cannabinoid Technologies Holdings Quick Ratio Related Terms

Thank you for viewing the detailed overview of Oxford Cannabinoid Technologies Holdings's Quick Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Oxford Cannabinoid Technologies Holdings (FRA:0CB) Business Description

Traded in Other Exchanges
Address
267 Banbury Road, Prama House, Oxford, GBR, OX2 7HT
Oxford Cannabinoid Technologies Holdings PLC is a pharmaceutical company engaged in cannabinoid drug development. The company uses a drug development that includes proprietary cannabinoid derivatives, natural phytocannabinoids (pCBs), and in-licensed compounds. Its primary market focus is the pain market, and OCT initially aims to develop a portfolio of four drug candidates for approval as licensed pain medicines.

Oxford Cannabinoid Technologies Holdings (FRA:0CB) Headlines

No Headlines